Viewing Study NCT05308966


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-03 @ 7:27 PM
Study NCT ID: NCT05308966
Status: COMPLETED
Last Update Posted: 2025-10-06
First Post: 2022-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
Sponsor: Groupe Francais De Pneumo-Cancerologie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module